阿片类药物使用障碍患者初次全髋关节置换术后植入物相关并发症的配对对照分析
基于2005至2014年Medicare数据,将阿片类药物使用障碍(OUD)患者按1:5匹配非OUD对照,共纳入42,097例初次全髋关节置换(THA)患者。OUD组2年植入物相关并发症、90天假体周围感染(PJI)和90天再入院风险及费用均高于对照。作者认为该结果有助于骨科医生向患者告知THA术后可能出现的并发症。
要点
- OUD组2年植入物相关并发症11.99% vs 6.68%,RR 1.74(P < .001)。
- OUD组90天PJI 2.38% vs 1.81%,RR 1.32(P = .001)。
- OUD组90天再入院21.49% vs 17.35%,RR 1.23(P < .001)。
核心结论
- 在控制年龄、性别、合并症指数及多种内科合并症后,OUD患者初次THA术后发生植入物相关并发症、PJI、再入院的风险及费用均高于非OUD患者。
- 作者认为该研究有助于骨科医生向患者告知初次THA术后可能出现的并发症。
研究设计与样本
- 回顾性配对对照分析,纳入2005至2014年接受初次THA的OUD患者,按年龄、性别、合并症指数及多种内科合并症以1:5比例匹配对照,共42,097例患者平均分布于两组。
- 采用Pearson卡方检验比较人口学特征,采用相对危险度(RR)分析2年植入物相关并发症、90天PJI及90天再入院率,采用Welch t检验比较手术当日及90天诊疗费用,P值小于.006视为有统计学意义。
主要发现
- OUD组2年植入物相关并发症发生率为11.99%,对照组为6.68%,RR 1.74(P < .001)。
- OUD组90天PJI发生率为2.38%,对照组为1.81%,RR 1.32(P = .001)。
- OUD组90天再入院率为21.49%,对照组为17.35%,RR 1.23(P < .001)。
- OUD组手术当日费用为14,384.30美元,对照组为13,150.12美元(P < .0001);OUD组90天费用为21,183.82美元,对照组为18,709.02美元(P < .0001)。
临床怎么用
- 作者认为该研究有助于骨科医生向患者告知初次THA术后可能出现的并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid use disorders (OUD) are a major cause of morbidity and mortality. The authors of this study hypothesize that patients who have an OUD will have greater relative risk of implant-related complications, periprosthetic joint infections (PJIs), readmission rates, and will incur greater costs compared to non-opioid use disorder (NUD) patients following primary total hip arthroplasty (THA). METHODS: OUD patients who underwent a THA between 2005 and 2014 were identified and matched to controls in a 1:5 ratio according to age, sex, a comorbidity index, and various medical comorbidities yielding 42,097 patients equally distributed in both cohorts. Pearson's chi-square analyses were used to compare patient demographics. Relative risk (RR) was used to analyze and compare risk of 2-year implant-related complications, 90-day PJIs, and 90-day readmission rates. Welch's t-tests were used to compare day of surgery and 90-day episode-of-care costs between the cohorts. A P value less than .006 was considered statistically significant. RESULTS: OUD patients had higher incidences and risks of implant-related complications (11.99% vs 6.68%; RR, 1.74; P < .001), developing PJIs within 90 days (2.38% vs 1.81%; RR, 1.32; P = .001), and 90-day readmissions (21.49% vs 17.35%; RR, 1.23; P < .001). Additionally, the study demonstrated OUD patients incurred greater day of surgery ($14,384.30 vs $13,150.12, P < .0001) and 90-day costs ($21,183.82 vs $18,709.02, P < .0001) compared to controls. CONCLUSION: After controlling for age, sex, a comorbidity index, and various medical complications, OUD patients are at greater risk to experience implant-related complications, PJIs, readmissions, and have greater costs following primary THA compared to non-OUD patients. This study should help orthopedic surgeons counsel their patients of potential complications which may arise following their primary THA.
引用
- Vakharia RM, Sabeh KG, Sodhi N, et al. Implant-Related Complications Among Patients With Opioid Use Disorder Following Primary Total Hip Arthroplasty: A Matched-Control Analysis of 42,097 Medicare Patients. J Arthroplasty. 2019. PMID: 31471183. doi:10.1016/j.arth.2019.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。